STOCK TITAN

Bayview Acquisition Corp Unit 8-K Filings

BAYAU NASDAQ

Every 8-K that Bayview Acquisition Corp Unit (BAYAU) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow BAYAU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BAYAU filings page.

Rhea-AI Summary

Bayview Acquisition Corp (BAYA) deposited $50,000 into its trust account on October 16, 2026, to extend by one month the period to complete an initial business combination, moving the date from October 19, 2026, to November 19, 2026.

Rhea-AI Summary

Bayview Acquisition Corp (BAYA) reports that on September 17, 2026, it deposited $50,000 into its trust account to extend the period it has to complete its initial business combination by one month. This extension moves the deadline from September 19, 2026 to October 19, 2026.

The company states that this is the fourth of up to six extensions permitted under its Second Amended and Restated Articles of Association, as amended. Bayview Acquisition Corp remains an emerging growth company with units, ordinary shares, and rights listed on The Nasdaq Stock Market LLC.

Rhea-AI Summary

Bayview Acquisition Corp reported that on August 14, 2026 it deposited $50,000 into its trust account to obtain a one-month extension of the deadline to complete its initial business combination. This extends the deadline from August 19, 2026 to September 19, 2026.

The company states this is the third of up to six extensions allowed under its Second Amended and Restated Articles of Association, as amended. The units, ordinary shares, and rights of Bayview Acquisition Corp continue to trade on The Nasdaq Stock Market LLC under the symbols BAYAU, BAYA, and BAYAR, respectively.

Rhea-AI Summary

Bayview Acquisition Corp deposited $50,000 into its trust account on July 14, 2026 to extend the period it has to consummate its initial business combination by one month, moving the deadline from July 19, 2026 to August 19, 2026. This Extension is described as the second of up to six extensions permitted under the Company’s Second Amended and Restated Articles of Association, as amended.

Rhea-AI Summary

Bayview Acquisition Corp reports that a Nasdaq Hearings Panel has decided to delist its securities after the company failed to complete its business combination with Oabay, Inc. by June 19, 2026, a condition for continued listing.

Nasdaq will suspend trading of Bayview’s units, ordinary shares and rights on July 7, 2026, and a Form 25-NSE will remove them from Nasdaq listing and registration. Bayview plans to ask the Nasdaq Listing and Hearing Review Council to review the delisting decision within the allowed 15-day window, but there is no assurance this review will change the outcome.

Rhea-AI Summary

Bayview Acquisition Corp deposited $50,000 into its trust account to buy more time to complete its first acquisition. This payment extends the deadline to consummate its initial business combination by one month, shifting it from June 19, 2026 to July 19, 2026.

The company describes this as the first of up to six possible one-month extensions allowed under its current Second Amended and Restated Articles of Association. The payment creates a direct financial obligation tied to maintaining the SPAC’s opportunity to close a qualifying deal.

Rhea-AI Summary

Bayview Acquisition Corp filed an amended report detailing shareholder approval to extend its deadline to complete an initial business combination. The company can now push its Termination Date from June 19, 2026 to December 19, 2026 through up to six one-month extensions, each requiring a $50,000 deposit into the Trust Account.

At the May 28, 2026 extraordinary general meeting, 2,291,094 ordinary shares, or about 83.67% of shares outstanding as of the record date, were represented, and both the charter amendment and trust agreement amendment passed unanimously. Ten holders redeemed 124,156 ordinary shares at approximately $12.11 per share, for total redemptions of about $1,503,642.93.

Rhea-AI Summary

Bayview Acquisition Corp shareholders approved extending the deadline to complete its initial business combination from June 19, 2026 to as late as December 19, 2026, through up to six one‑month extensions, each requiring a $50,000 deposit into the trust account.

At the extraordinary general meeting, holders of 2,291,094 ordinary shares, about 83.67% of shares as of the May 4, 2026 record date, were represented, and both the charter amendment and trust agreement amendment passed unanimously.

Only 124,156 shares, representing less than 5% of total shares outstanding, were redeemed at approximately $12.03 per share, for about $1.49 million in total. The company highlighted that this low redemption level supports its efforts to complete a business combination with Oabay Inc.

Rhea-AI Summary

Bayview Acquisition Corp has amended its merger agreement again, extending the deadline to close its planned business combination. On May 19, 2026, the parties signed Amendment No. 4, moving the Outside Closing Date to December 19, 2026 from the prior June 15, 2026.

This follows earlier amendments that revised earnout milestones based on new consolidated revenue metrics and realigned the transaction sequence. The report notes that forward-looking statements are subject to risks and uncertainties, and there is no assurance the company will achieve the expectations described.

Rhea-AI Summary

Bayview Acquisition Corp deposited $50,000 into its trust account on May 15, 2026 to obtain a one‑month extension of the deadline to complete its initial business combination, moving it from May 19, 2026 to June 19, 2026.

This is the sixth and final extension allowed under the company’s current Second Amended and Restated Articles of Association.

Rhea-AI Summary

Bayview Acquisition Corp received a favorable decision from a Nasdaq Hearings Panel allowing its shares, units and rights to remain listed, with trading moved from the Nasdaq Global Market to the Nasdaq Capital Market effective April 24, 2026.

The extension is conditional. Bayview must close its proposed business combination with Oabay Inc. and meet Nasdaq’s initial listing standards by June 19, 2026, while also complying with ongoing listing rules. Failure to satisfy these conditions could still lead to delisting despite the current exception.

Rhea-AI Summary

Bayview Acquisition Corp deposited $50,000 into its trust account to extend the deadline to complete its initial business combination. This payment moves the cutoff date from April 19, 2026 to May 19, 2026, providing one additional month to close a deal.

The company states this is the fifth of up to six permitted extensions under its Second Amended and Restated Articles of Association.

Rhea-AI Summary

Bayview Acquisition Corp reported the results of its annual general meeting of shareholders held on April 10, 2026. Shareholders approved all matters presented, as described in the company’s definitive proxy statement filed on March 23, 2026.

A total of 2,738,292 ordinary shares were entitled to vote as of March 2, 2026, and holders of 2,274,294 shares were present in person or by proxy, representing 83.05% of eligible shares. One item received 2,184,194 votes in favor, with 90,100 broker non-votes, indicating that each proposal passed with strong shareholder support.

Rhea-AI Summary

Bayview Acquisition Corp reports additional Nasdaq listing problems that heighten its delisting risk. The company previously received a determination to delist its securities and has applied to move from The Nasdaq Global Market to The Nasdaq Capital Market, but that transfer is still pending approval.

Bayview has now been notified it is out of compliance with Nasdaq Listing Rule 5450(b)(2)(B), which requires at least 1,100,000 publicly held shares. A hearing before a Nasdaq Hearings Panel is scheduled for March 31, 2026, where the company plans to address this and other deficiencies, though there is no assurance it will regain compliance or avoid delisting.

Rhea-AI Summary

Bayview Acquisition Corp deposited $50,000 into its trust account on March 16, 2026 to extend the deadline to complete its initial business combination by one month, moving the date from March 19, 2026 to April 19, 2026.

This payment represents the fourth of up to six one-month extensions allowed under the company’s Second Amended and Restated Articles of Association, as amended.

Rhea-AI Summary

Bayview Acquisition Corp filed an amended report to update details about a Nasdaq delisting notice. Nasdaq’s Listing Qualifications Staff informed the company on February 19, 2026 that it remains out of compliance with three listing standards: the $50.0 million Market Value of Listed Securities requirement, the minimum 400 total shareholders requirement, and the rule requiring an annual shareholder meeting within twelve months of fiscal year-end.

Nasdaq determined that Bayview’s securities will be delisted from The Nasdaq Global Market unless the company appeals by February 26, 2026. If it does not appeal, trading will be suspended at the opening on March 2, 2026 and a Form 25-NSE will be filed to remove the securities from listing and registration. Bayview intends to appeal to a Nasdaq Hearings Panel, which would temporarily stay any suspension and delisting while the Panel considers the case, but there is no assurance the appeal will succeed.

Rhea-AI Summary

Bayview Acquisition Corp reports that Nasdaq has determined its securities are subject to delisting after the company failed to regain compliance with multiple listing standards. The company has not met the Market Value of Listed Securities requirement of $50.0 million and the Market Value of Publicly Held Shares requirement of $15.0 million, and it also did not hold an annual shareholder meeting within twelve months of its fiscal year end.

Nasdaq’s staff stated that Bayview’s securities will be delisted from the Nasdaq Global Market unless the company appeals by February 26, 2026. If no appeal is made, trading is expected to be suspended at the opening on March 2, 2026 and a Form 25-NSE will remove the securities from listing and registration. Bayview intends to appeal to a Nasdaq Hearings Panel, which would temporarily stay any suspension and delisting actions, but there is no assurance the appeal will succeed.

Rhea-AI Summary

Bayview Acquisition Corp reported that Nasdaq’s Listing Qualifications staff notified the company on February 12, 2026 that it is not in compliance with Nasdaq Listing Rule 5620(a), which requires holding an annual shareholder meeting within twelve months of fiscal year-end.

The notice is a deficiency notification only and does not immediately affect the listing or trading of Bayview’s units, ordinary shares, or rights on the Nasdaq Global Market. Bayview has until March 30, 2026 to submit a plan to regain compliance and intends to do so. If Nasdaq accepts the plan, the company may have until June 29, 2026 to demonstrate compliance, with the option to appeal if Nasdaq does not accept its plan.

Rhea-AI Summary

Bayview Acquisition Corp disclosed that it made a $50,000 cash deposit into its trust account on February 13, 2026. This payment extends the deadline to complete its initial business combination by one month, from February 19, 2026 to March 19, 2026.

The company notes this is the third extension out of up to six allowed under its Second Amended and Restated Articles of Association. The item is reported as the creation of a direct financial obligation or an off‑balance sheet obligation.

Rhea-AI Summary

Bayview Acquisition Corp has amended its merger agreement and received a Nasdaq listing deficiency notice. The Third Amendment to the Merger Agreement extends the Outside Closing Date to June 15, 2026, giving more time to complete the proposed business combination with Oabay-related entities.

Separately, Nasdaq notified Bayview on January 16, 2026 that it is not in compliance with the Market Value of Publicly Held Shares requirement, which calls for a minimum MVPHS of $15.0 million. Bayview has 180 days, until July 15, 2026, to regain compliance by having its MVPHS close at or above $15.0 million for at least ten consecutive business days. The notice does not immediately affect trading, but failure to regain compliance could lead to delisting, subject to potential appeal.

Rhea-AI Summary

Bayview Acquisition Corp reported that on September 18, 2025 it deposited $100,000 into its trust account to obtain a one-month extension to complete its initial business combination. This payment extends the deadline from September 19, 2025 to October 19, 2025.

The company notes that this is the fourth extension of up to six extensions permitted under its Second Amended and Restated Articles of Association, as amended. The payment creates a direct financial obligation tied to maintaining the SPAC’s ability to seek and close a qualifying business combination.

Rhea-AI Summary

Bayview Acquisition Corp reported that Nasdaq has notified the company it is out of compliance with Nasdaq Listing Rule 5450(b)(2)(A), which requires a minimum Market Value of Listed Securities of $50.0 million. This is a deficiency notice only and does not immediately affect the trading or listing of its units, ordinary shares, or rights on the Nasdaq Global Market.

The company has 180 calendar days, until February 18, 2026, to regain compliance by maintaining a market value of listed securities of at least $50.0 million for ten consecutive business days. If it fails to do so, its securities may be subject to delisting, though the company would be able to appeal to a Nasdaq Hearing Panel. Bayview Acquisition Corp states that it intends to monitor its market value and consider available options to regain compliance.

Rhea-AI Summary

Bayview Acquisition Corp Unit deposited $100,000 into its trust account to extend the period to consummate its initial business combination by one month, moving the deadline from August 19, 2025 to September 19, 2025. This Extension is the third of up to six extensions permitted under the Company’s Second Amended and Restated Articles of Association currently in effect. The filing discloses only the extension payment and the new one-month deadline; no other transaction details, target identity, or additional financing terms are provided.

Rhea-AI Summary

Form 8-K Overview – Bayview Acquisition Corp (NASDAQ: BAYAU)

The SPAC filed an 8-K to disclose a short-term one-month extension of its deadline to close an initial business combination. On 20 June 2025 the company deposited $100,000 into its trust account, extending the deadline from 19 June 2025 to 19 July 2025. This is the first of up to six monthly extensions allowed under the company’s Second Amended & Restated Articles of Association.

To finance both the extension deposit and future working-capital needs, Bayview issued an unsecured, zero-interest promissory note for up to $600,000 to Oabay Inc. and its operating entity AsiaFactor(CN) Co., Ltd. Principal is payable only when Bayview consummates a business combination with the payees, indicating a potential alignment with a future target. No interest accrues, and the note represents a direct financial obligation and an off-balance-sheet arrangement under Item 2.03.

No other material financial metrics, earnings data or changes in control were disclosed. The filing signals that Bayview has not yet finalized a merger partner and will bear additional obligations if the combination process continues to be delayed.

Rhea-AI Summary

Bayview Acquisition Corp (Nasdaq: BAYAU/BAYA/BAYAR) disclosed in its Form 8-K that shareholders approved two key proposals at the 17 June 2025 extraordinary general meeting. The Extension Amendment lets the special-purpose acquisition company (SPAC) postpone its deadline to complete an initial business combination up to six times, from 19 June 2025 to 19 December 2025, in one-month increments. Parallel to this, the Trust Agreement Amendment permits each extension provided the company deposits $100,000 per month into the trust and enables the trustee to liquidate the account if an extension payment is missed after a 30-day cure period.

Both resolutions passed with identical tallies—4,585,968 votes FOR versus 586,502 AGAINST—representing approximately 95 % of the 5,172,470 shares outstanding on the record date. The back-up Adjournment Proposal was not acted upon.

Importantly, 1,975,249 ordinary shares (≈38 % of shares outstanding) were redeemed at $11.05 per share, removing roughly $21.83 million from the trust. Post-redemption, the public float falls to about 3.20 million shares and the trust balance declines correspondingly, lowering funds available for a future merger but boosting per-share trust value for remaining shareholders. The outcome gives management breathing room to source a target while introducing incremental monthly cash leakage and signalling a meaningful level of investor dissent via redemptions.